Oncology Central

New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?


Breast cancer is the most common malignant disease in women in the Western world, with an annual incidence rate of approximately 110/100,000 in females in the EU. Despite tremendous improvements in therapy in the last decades, one in five breast cancer patients dies from their disease.

To view restricted content, please:

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.